Univestin®: Fast Mobility Support for Sedentary Routines

Sedentary behaviours, prolonged screen use and reduced daily movement are reshaping today’s joint health market. While joint discomfort was once closely associated with aging populations, increasingly it is being reported by younger, working‑age consumers experiencing stiffness and reduced mobility linked to modern lifestyles.

This shift is driving demand for fast‑acting, natural joint health ingredients like Univestin® that deliver noticeable benefits within days rather than weeks. Univestin® is a patented, plant‑based ingredient standardised to bioflavonoids from Scutellaria baicalensis and Acacia catechu, designed to support joint comfort, flexibility and mobility via a multi‑pathway mechanism. Human clinical data¹ showed improvements in joint flexibility and comfort within 3-7 days, supporting formulations for time‑pressured consumers.

Discovered through Unigen’s proprietary botanical screening platform, Univestin® was selected from over 1,200 medicinal plants for its ability to modulate key pathways involved in joint stiffness and discomfort. This multi‑target approach helps differentiate Univestin® from single‑mechanism solutions and supports broader formulation strategies, whether used as a standalone ingredient or as part of a combination  joint health concept. With a low recommended daily dose^1,2 (250–500 mg) and extensive safety validation³, Univestin® also offers clear advantages in formulation flexibility and compliance.

Read more to explore how Univestin® can help elevate next‑generation joint health formulations focused on faster mobility support. Download our Univestin® Product Profile Sheet here or contact us.

_{References
(1) Arjmandi B.H., et al (2014) A Combination of Scutellaria Baicalensis and Acacia Catechu Extracts for Short-Term Symptomatic Relief of Joint Discomfort Associated with Osteoarthritis of the Knee.
(2) Sampalis J., et al. (2012) A randomized, double blind, placebo and active comparator controlled pilot study of UP446, a novel dual pathway inhibitor anti-inflammatory agent of botanical origin.
(3) Intertek Scientific & Regulatory Consultancy Health, Environmental & Regulatory Services. 2018. Safety Evaluation of Univestin.}